Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]

Detalles Bibliográficos
Autores principales: Jain, Samagra, Venkataraman, Abhijeet, Wechsler, Marissa E., Peppas, Nicholas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413842/
https://www.ncbi.nlm.nih.gov/pubmed/36031502
http://dx.doi.org/10.1016/j.addr.2022.114501
_version_ 1784775850064871424
author Jain, Samagra
Venkataraman, Abhijeet
Wechsler, Marissa E.
Peppas, Nicholas A.
author_facet Jain, Samagra
Venkataraman, Abhijeet
Wechsler, Marissa E.
Peppas, Nicholas A.
author_sort Jain, Samagra
collection PubMed
description
format Online
Article
Text
id pubmed-9413842
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94138422022-08-26 Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000] Jain, Samagra Venkataraman, Abhijeet Wechsler, Marissa E. Peppas, Nicholas A. Adv Drug Deliv Rev Corrigendum Elsevier B.V. 2022-10 2022-08-26 /pmc/articles/PMC9413842/ /pubmed/36031502 http://dx.doi.org/10.1016/j.addr.2022.114501 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Jain, Samagra
Venkataraman, Abhijeet
Wechsler, Marissa E.
Peppas, Nicholas A.
Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title_full Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title_fullStr Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title_full_unstemmed Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title_short Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
title_sort corrigendum to “messenger rna-based vaccines: past, present, and future directions in the context of the covid-19 pandemic” [adv. drug delivery rev. 179 (2021) 114000]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413842/
https://www.ncbi.nlm.nih.gov/pubmed/36031502
http://dx.doi.org/10.1016/j.addr.2022.114501
work_keys_str_mv AT jainsamagra corrigendumtomessengerrnabasedvaccinespastpresentandfuturedirectionsinthecontextofthecovid19pandemicadvdrugdeliveryrev1792021114000
AT venkataramanabhijeet corrigendumtomessengerrnabasedvaccinespastpresentandfuturedirectionsinthecontextofthecovid19pandemicadvdrugdeliveryrev1792021114000
AT wechslermarissae corrigendumtomessengerrnabasedvaccinespastpresentandfuturedirectionsinthecontextofthecovid19pandemicadvdrugdeliveryrev1792021114000
AT peppasnicholasa corrigendumtomessengerrnabasedvaccinespastpresentandfuturedirectionsinthecontextofthecovid19pandemicadvdrugdeliveryrev1792021114000

Ejemplares similares